Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and ECG Effects of Dextromethorphan in Healthy Subjects
NCT02191176Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2009
- Primary completion
- Jul 2009
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of dextromethorphan in cough (3 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Number of patients with abnormal findings in physical examination, Number of patients with clinically significant changes in vital signs and 4 more. Started Jun 2009; status: completed.
02
Drugs
dextromethorphan
03
Conditions
cough
Beyond the preview
Go deeper on NCT02191176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02191176.